On Thursday, Endo International plc - Ordinary Shares (NASDAQ:ENDP)’s shares declined -4.15% to $80.82.
Endo International plc (ENDP) , declared the planned divestiture of a portfolio of device, vaccine and other non-core products from its international partner in South Africa , Litha Healthcare Group, to a consortium comprised of Westrate Trade and Invest Proprietary Limited (Westrate) and Immunotek (Pty) Limited (Immunotek). The transaction is predictable to be accomplished in the fourth quarter of 2015 subject to regulatory consents and is not predictable to have a material impact on Endo’s financial results this year. This divestiture continues the transformation of Litha and strengthens its planned focus on pharmaceutical products. In May 2015 , Endo declared the acquisition of a broad portfolio of 60 on-market products and nearly 70 R&D pipeline programs that will be incorporated into Litha from a partner of Aspen Holdings, a leading publicly-traded South African company. The Aspen transaction, which is projected to close in the third quarter 2015, is predictable to meaningfully expand Endo’s pharmaceutical presence in South Africa and to be right away accretive to earnings.
Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S. Branded Pharmaceuticals segment provides various branded prescription products, counting Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Fortesta Gel, Supprelin LA, Valstar, Vantas, Sumavel DosePro, Aveed, and Natesto to treat and manage pain and conditions in urology, endocrinology, and oncology. The U.S. Generic Pharmaceuticals segment offers products in the pain administration, urology, CNS disorders, immunosuppression, oncology, women’s health, hypertension, generic lidocaine patch, and other markets.
Aramark (NYSE:ARMK)’s shares dropped -2.54% to $32.64.
The Philadelphia Eagles and Aramark, the team’s longtime food and beverage provider, have announced a seven-year extension of its partnership at Lincoln Financial Field. Aramark, which has been a partner with the Eagles since 2005, will continue to oversee and manage the concessions, club levels, suites and restaurant dining areas at Lincoln Financial Field.
Over the course of the partnership, the Eagles and Aramark have collaborated on a joint effort to showcase new and unique food and beverage options to fans every season, with a specific focus on Philadelphia’s distinctive tastes and flavors. In 2013, the two sides partnered with renowned chefs and restaurateurs, counting Marc Vetri and Peter McAndrews. Since then, fans have had the opportunity to choose from a variety of new meal options that feature each culinary partner’s signature dishes and one-of-a-kind techniques.
Aramark provides food, facilities, and uniform services to education, healthcare, business and industry, sports, leisure, and corrections clients primarily in North America. The company offers managed services, counting dining, catering, food service administration, convenience-oriented retail operations, grounds and facilities maintenance, custodial, energy and construction administration, and capital project administration. I
At the end of Thursday’s trade, Horizon Pharma PLC (NASDAQ:HZNP)‘s shares dipped -5.15% to $29.66.
Horizon Pharma plc ( HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, recently named George Hampton as executive vice president, global orphan business unit and international operations, reporting directly to Timothy P. Walbert, chairman, president and chief executive officer, effective right away. Hampton has also joined the Horizon’s Executive Committee.
Hampton joined Horizon Pharma in 2008 as a consultant and full time as a group vice president, international operations in April 2015. Most recently, Hampton served as president and chief executive officer of a privately held technology company. He also has more than 20 years of experience as a successful executive in the pharmaceutical and biotech field on both a national and international scale counting specific expertise in the autoimmune (HUMIRA), primary care (CELEBREX), orthopedic, diabetes (BYETTA), anti-infectives and cardiovascular areas. This comprises 10 product launches in roles of increasing responsibility in sales, international marketing and operations at G.D. Searle, Abbott (now AbbVie) and Amylin Pharmaceuticals. Hampton holds a bachelor’s degree from Miami University in Oxford, Ohio.
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally.
Tech Data Corp (NASDAQ:TECD), ended its Thursday’s trading session with 13.12% gain, and closed at $63.65.
Tech Data Corp (NASDAQ:TECD) and Sphere 3D Corp. (NASDAQ: ANY), declared the expansion of their agreement through Sphere 3D’s wholly owned partner, Overland Storage. The agreement allows Sphere 3D’s innovative cloud and hybrid cloud solutions to be accessible for purchase by solution providers from Tech Data’s Cloud Solutions Store. The new offerings will enable solution providers to offer to end user customers virtualization and data administration solutions such as Sphere 3D’s SnapCLOUD™, a virtual enterprise NAS storage platform.
The explosive growth of data and the demand to access it anywhere at any time brings with it a new set of challenges for data protection, administration and mobility, causing enterprises to evaluate how to leverage the cloud and on-premise infrastructure to deliver the best user experience. Designed for easy integration and optimal performance, Sphere 3D’s data administration solutions can be deployed via on-premise appliances or cloud-based services and directly address customers’ needs to centrally manage and deliver all of their enterprise data in a secure manner.
Tech Data Corporation engages in the wholesale distribution of technology products. It distributes and markets broadline products, such as notebooks, tablets, desktop systems, printers, supplies, and components; and data center products, counting servers, server accessories, networking products, storage hardware, and networking support services. The company also offers software products, such as virtualization software, security software, desktop application software, operating system software, utilities software, and software service and support; mobility products compriseing of mobile handsets, navigation devices, aircards, SIM cards, and other mobility-related accessories; and consumer electronics comprising car and home audio/visual equipment, blue-ray and DVD players, televisions and related accessories, cameras and related accessories, gaming, and home appliances, in addition to logistics administration and other value-added services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
